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Abstract
Background Xanthogranulomas are inflammatory masses most commonly found at peripheral sites such as the skin. Sellar 
and parasellar xanthogranulomas are rare and present a diagnostic challenge as they are difficult to differentiate from other 
sellar lesions such as craniopharyngiomas and Rathke’s cleft cysts pre-operatively. Their radiological imaging features are 
yet to be clearly defined, and clinical outcomes after surgery are also uncertain. This study reviews clinical presentation, 
radiological appearances, and clinical outcomes in a cohort of patients with pituitary xanthogranulomas.
Methods A prospectively maintained pituitary surgery database was screened for histologically confirmed pituitary xan-
thogranulomas between May 2011–December 2016. Retrospective case note assessments were then performed by three 
independent reviewers. Patient demographics, clinical presentations, imaging, and clinical outcomes were analysed.
Results During the study period 295 endoscopic endonasal pituitary surgeries were performed. Six patients had confirmed 
pituitary xanthogranulomas (2%). Patients most commonly presented with visual field deficits and/or endocrine dysfunc-
tion. Common imaging features included: a cystic consistency, hyperintensity on T1-weighted MR images, and contrast 
enhancement either peripherally (n = 3) or homogenously (n = 3). The most common pre-operative endocrine deficits were 
hyperprolactinaemia and hypoadrenalism (at least one of which was identified in 4/6 patients; 66%). Thirty-three percent (2/6) 
of patients presented with diabetes insipidus. The most common post-operative endocrinological deficits were adrenocortical 
dysfunction (66%) and gonadotropin deficiency (66%). Visual assessments normalised in all six patients post-operatively. 
Gross total resection was achieved in all patients, and at median follow up of 33.5 months there were no cases of tumour 
recurrence.
Conclusions The prevalence of pituitary xanthogranulomas in our series is higher than that suggested in the literature. Surgery 
restored normal vision to all cases, however four patients (67%) required long-term hormonal replacement post-operatively. 
Imaging features such peripheral rim enhancement, a suprasellar tumour epicentre, and the absence of both calcification 
or cavernous sinus invasion were identified as potential indicators that together should alert clinicians to the possibility of 
pituitary xanthogranuloma when assessing patients with cystic sellar and parasellar tumours.
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Introduction and aims
Xanthogranulomas are a pathological entity thought to 
result from a process of chronic inflammation. Characteris-
tic histology findings include foamy macrophage infiltration, 
central necrosis, multinucleated giant cells and haemosiderin 
deposition [1]. They most commonly develop at peripheral 
sites, such as the skin or eye. They rarely develop intracrani-
ally, and only a handful of case reports and series describe 
xanthogranulomas developing in the parasellar or sellar 
regions, with their prevalence amongst pituitary tumour 
patients reported at ~ 0.6% [2]. They are often only diag-
nosed post-operatively, due to their clinical and radiological 
similarity to more common sellar lesions such as craniophar-
yngiomas (CPs) and Rathke’s cleft cysts (RCCs). Due to the 
rarity of xanthogranulomas, the long-term endocrine and 
clinical outcomes have been largely unexplored. Similarly 
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defining radiological appearances to aid pre-operative diag-
nosis and operative planning have not been well described.
This retrospective study reviews the clinical presentation, 
radiological appearances, endocrine outcomes, and tumour 
recurrence rates in a cohort of patients with confirmed pitui-
tary xanthogranulomas.
Methods
Histologically confirmed cases of pituitary xanthogranuloma 
between May 2011–December 2016 were identified from 
a prospectively maintained pituitary surgery database at a 
single neurosurgical unit. A retrospective case note review 
was performed by three independent reviewers to collect 
data on patient demographics, presenting symptoms, endo-
crine function pre-and post-operatively, visual outcomes and 
tumour recurrence. Pre-operative MR imaging was reviewed 
by a senior neurosurgeon. Maximum tumour diameter, 
tumour consistency, (solid/cystic) enhancement pattern, T1/
T2 signal characteristics and cavernous sinus involvement 
were recorded. The method of evaluating parasellar tumour 
growth pattern and origin introduced by Petrakakis et al. [3] 
was utilised. This involves division of the parasellar region 
into 4 quadrants on a midline sagittal T2-weighted (T2W) 
image to evaluate the growth pattern of pituitary lesions 
(Fig. 1). The 4 quadrants are defined by two hypothetical 
lines, one connecting the planum sphenoidale and the dor-
sum sellae, (light blue line) and another, (dark blue) cross-
ing perpendicularly to the first line where the pituitary stalk 
would descend through the diaphragma sellae. This para-
digm permits comparison of the tumour epicentres, and can 
help define differential growth patterns of sellar and para-
sellar tumours.
Results
Demographics and presenting features
During the study period 295 patients underwent endoscopic 
endonasal pituitary surgery, of which 6 (2%) had histologi-
cally confirmed xanthogranulomas. Four patients (67%) 
were female and 2 were male. The mean age of patients 
at presentation was 28.6 years (range 10–63 years). The 
mean duration of symptoms before a diagnosis made was 
6.6 months (median 5 months, range 1–18 months).
The most common presenting symptoms were visual 
deterioration (4/6; 67%), endocrinological dysfunction 
(4/6; 67%), and headaches (3/6; 50%). Patients presented 
with a range of endocrine issues, (Table 1). Two patients 
(33%) presented with polyuria and polydipsia, one of 
which met the medical criteria for diabetes insipidus. 
Only one patient (17%) presented with irregular periods 
and galactorrhoea, however biochemical hyperprolacti-
naemia was subsequently confirmed in a total of 4 cases 
(67%) within the cohort. Pre-operative trials of a dopamine 
agonists (bromocriptine or carbergoline) in three of these 
patients had no influence upon on tumour size or prolactin 
levels. Biochemical adrenal and thyroid axis deficiency 
was identified in 4 (67%) patients at presentation. Gonadal 
axis dysfunction was noted in two patients (33%). One 
patient (17%) had biochemical growth hormone deficiency 
pre-operatively.
All patients underwent surgery, either transsphenoidal 
hypophysectomy, (5/6) or craniotomy (1/6) via techniques 
described previously [4]. The pituitary stalk was preserved 
in all but one case, wherein adherence of the tumour to 
the stalk necessitated sacrifice of the structure to obtain 
adequate tumour clearance as the pre-operative radiologi-
cal diagnosis was thought to be craniopharyngioma. Intra-
operative frozen section analysis was not undertaken in 
this case. Gross total resection (GTR) was achieved in all 
Fig. 1  The method utilised to evaluate suprasellar tumour growth, 
adapted from Petrakakis et  al. The four quadrants used to define 
tumour expansion are outlined; the quadrant housing the tumour epi-
centre, and growth within each quadrant, can be assessed individu-
ally. Quadrant 1 represents the suprasellar preinfundibular region, 
quadrant 2 the suprasellar retroinfundibular region, quadrant 3 the 
clival sellar region, and quadrant 4 the nasal sellar region. Adapted 
from: Petrakakis et al. [3] The sellar and suprasellar region: A “hidea-
way” of rare lesions. Clinical aspects, imaging findings, surgical out-
come and comparative analysis. Clinical Neurology and Neurosur-
gery. 149:154–165
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cases, defined as the absence abnormal enhancing tissue 
on post-op imaging performed within 8 weeks of surgery.
Pre‑operative imaging features
The most common imaging features, present in 100% (n = 6) 
of patients were: sellar expansion; a cystic nature to the 
tumour, some degree of contrast enhancment, and locali-
sation of the tumour epicentre in quadrant 1 (suprasellar, 
preinfundibular region). Five patients (83%) had the pres-
ence of stalk thickening, and some degree of lesion hyper-
intensity on T1-weighted (T1W) images (Fig. 2). 67% of 
patients (n = 4) had optic nerve compression pre-operatively. 
Xanthogranuloma was not listed in any of the patients’ dif-
ferential diagnosis based on pre-operative imaging features 
(Table 2). The most common radiological differential diag-
nosis was craniopharyngioma, reported as the most likely 
lesion in 50% (n = 3) of patients. The mean maximum 
diameter of tumours was 20 mm (median 18 mm, range 
13–29 mm). There was no calcification or cavernous sinus 
invasion in any cases. Pre-operative imaging features are 
further outlined in Table 2 and defining features outlined in 
Fig. 2. All cases are demonstrated in Fig. 3.
Post‑operative hormone status
Prolactin levels completely normalised in all patients after 
surgery. Five patients (83%) required steroid replacement 
post-operatively. One of these patients had a normal steroid 
axis at 4 months postoperatively and hydrocortisone replace-
ment was thus ceased, leaving 67%, (4/6) of patients requir-
ing permanent steroid replacement (Table 3). Similarly, four 
patients (67%) also suffered with persistent secondary hypo-
thyroidism. One-third (2/6) of patients had growth hormone 
deficiency, one of which developed post-operatively. Two 
patients developed diabetes insipidus (DI) post-operatively, 
necessitating desmopressin therapy. One of these cases was 
transient and did not require long-term hormonal treatment. 
The other case of persistent DI is attributed to pituitary 
stalk transection during surgery, a decision made to facili-
tate complete removal of the tumour. One patient did not 
require any hormonal supplementation at the end of the ana-
lysed follow-up period (median 33.5 months; Table 3). The 
overall rates of persistent anterior hypopituitarism are 67%, 
and permanent DI occurred in 1 patient (16%). Amongst 
cases 3, 5 and 6, with tumour epicentres located in quadrant 
1, (Table 2) only one patient had a normal endocrine axis 
post-operatively (case 6). Additionally, tumour epicentre did 
not correlate with post-operative posterior pituitary function.
Table 1  Patient demographics and presenting features in the pituitary xanthogranuloma patient cohort
– indicates deficient, + indicates excess
Case 1 2 3 4 5 6
Gender Female Female Female Male Male Female
Age at presentation 63 39 17 25 18 10
Presenting symp-
toms
Polyuria and poly-
dipsia
Irregular peri-
ods, galactor-
rhoea
History of visual 
deterioration
Headaches in 
frontal parietal 
region and visual 
defects
Sudden onset 
of headache, 
polyuria and 
polydipsia, visual 
defects
Intermittent 
headaches and 
deterioration of 
left eye vision
Pituitary function at diagnosis
 Corticotropin axis – – Normal – – Normal
 Thyrotropin axis – – Normal – – Normal
 Gonadotropin axis Normal – Normal Normal – Normal
 Somatrotropin 
axis
Normal – Normal Normal Normal Normal
 ADH axis – Normal Normal Normal Normal Normal
 Prolactin + (1364) + (2823) + (1881) + (462) Normal Normal
Pre-operative treat-
ment
Bromocriptine trial, 
hydrocortisone, 
thyroxine and 
desmopressin
Cabergoline trial Cabergoline trial Hydrocortisone and 
levothyroxine
None None
Duration of 
symptoms before 
diagnosis
3 months 8 months 7 months 3 months 1 month 18 months
Co-morbidities Smoker Obesity None None Obesity None
259Pituitary (2018) 21:256–265 
1 3
Fig. 2  Case 5—Exemplar MR imaging findings in pituitary xan-
thogranuloma. There is a cystic lesion demonstrating peripheral rim 
contrast enhancement, and a tumour epicentre identifiable in quad-
rant 1. a T1 weighted sagittal (post-contrast); mixed intensity lesion 
with predominantly high T1W signal centrally, and peripheral rim 
enhancement. b T1 weighted coronal (pre-contrast); mixed intensity 
lesion with predominantly high T1W signal centrally. c T1 weighted 
coronal (post-contrast); mixed intensity lesion with predominantly 
high T1W signal centrally. The peripheral rim enhancement is easily 
appreciated in this image. d T2 weighted coronal; mixed intensities 
within the lesion, suggestive of the presence of both solid and cystic 
components
Table 2  Pre-operative imaging features of pituitary xanthogranulomas
– indicates absence, + indicates presence
Case 1 Case 2 Case 3 Case 4 Case 5 Case 6
Cystic + + + + + +
Rim enhancment + – – + – +
Central enhance-
ment
– + + – + +
Stalk thickening + – + + + +
Stalk enhancement + – – – – –
Maximum diameter 
(mm)
13 14 18 18 26 29
T1W MR signal Hyperintense Hyperintense Hypointense Hypointense Hyperintense-mixed Hyperintense-mixed
Cavernous sinus 
invasion
– – – – – –
Optic nerve com-
pression
– – + + + +
Sella expanded + + + + + +
Calcification – – – – – –
Quadrant 1 and 2 1 and 2 1 1 and 2 1 1
Differential diagno-
sis (pre-op)
Lymphocytic 
hypophysitis/
abscess
Craniopharyngioma 
or pituitary apo-
plexy
Cystic pituitary 
adenoma/ 
RCC 
Apoplexy/non-
functioning 
adenoma
Craniopharyngioma Craniopharyngioma
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Histology
The most common histological features identified were: 
multinucleated giant cells, CD68 positivity, and squamoid 
epithelium. These features were present in 67% (n = 4) of 
patients (Table 4). Haemosiderin and macrophages were 
found in 50% of patients. Granulomas, cholesterol clefts, 
granulation tissue, histiocytes, T and B lymphocytes, 
necrosis and plasma cells were found in 33% (n = 2) of 
patients.
Visual status pre‑ and post‑operatively
Sixty-seven percent (n = 4) of patients presented with 
visual defects, most commonly a bitemporal hemianopia 
(n = 3). One patient (17%) patient presented with com-
plete loss of vision in one eye (Table 5). However, post-
operative visual fields and visual acuity were recorded as 
normal in all six patients, regardless as to whether tumour 
epicentre was located in quadrant 1 or quadrants 1 and 2.
Extent of resection and recurrence
Complete GTR was achieved in 100% (n = 6) of patients. 
One patient required two surgeries to achieve this level of 
tumour clearance (Case 6); following the first surgery, a 
transcranial approach for a laterally based cyst, residual 
tumour was identified on routine 6-month follow-up imag-
ing. This residual tumour mass was subsequently resected 
completely via an endonasal endoscopic approach.
There was no post-operative CSF leak in any patients 
in the cohort. The pituitary stalk was preserved in 83% 
(n = 5) of patients. In the other case, the tumour mass was 
adherent to the stalk itself. The decision was made that 
the benefit of achieving GTR outweighed the disadvan-
tage of developing endocrine deficits, as the diagnosis was 
thought to be craniopharyngioma, (Case 4; Table 3).
No tumour recurrence has occurred to date in any 
patient after complete resection at a median follow-up 
of 33.5 months (range 6–90 months). Additionally, no 
patients have developed any other systemic evidence of 
inflammatory or granulomatous disease elsewhere.
Discussion
Intracranial xanthogranulomas arise most commonly in 
the choroid plexus at the trigone of the lateral ventricle; 
xanthogranulomas of the sellar region are much rarer [3]. 
The entity was first identified in 1988 [5], and was placed 
on the spectrum of cystic pathology occurring in the sellar 
region, incorporating CPs, RCCs, colloid cysts, cystic ade-
nomas, and dermoid cysts [6]. Paulus et al. [7] described 
xanthogranuloma of the sellar region as a distinct entity 
in 1999, identifying 37 cases wherein resected pituitary 
lesions consisted predominantly of xanthogranulomatous 
Fig. 3  a Representative T1W MR image of case (1) the T1W hyper-
intense sellar lesion is noted. b Representative T1W MR image of 
case (2) the lesion exhibits T1W hyperintensity, with a degree of het-
erogeneous signal centrally. c Representative T1W MR image of case 
(3) this lesion exhibits T1W iso- to- hypointensity, with prominent 
peripheral contrast enhancement. d Representative T1W MR image 
of case (4) this lesion exhibits T1W hypointensity, with prominent 
peripheral contrast enhancement. e Representative T1W MR image of 
case (5) this lesion exhibits T1W hyperintensity, with subtle contrast 
enhancement and central heterogeneous signal. f Representative T1W 
MR images of case (6) the sellar lesion demonstrates heterogeneous 
signal centrally, with a peripheral rim of contrast enhancement. The 
satellite lesion adjacent to the sella on the left-hand side exhibits sim-
ilar signal characteristics
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components once examined histologically. These lesions 
may be an individual disease entity, [7] or represent the 
outcome after repetitive inflammation and haemorrhage 
into a previously typical RCC or CP.
Demographics
Previous literature has reported the prevalence of sellar 
and parasellar xanthogranulomas in pituitary tumour 
patients the western hemisphere to be in the region of 0.6% 
[2]. The prevalence of xanthogranulomas in our study was 
2% (6/295), in keeping with another recent series which 
reported just under 3% of their pituitary tumour database 
comprised of xanthogranulomatous lesions (6/223) [3, 8]. 
Whilst it remains rare, as awareness of this disease entity 
has developed it appears to be more commonly identified 
on histology within the cohort of patients with cystic sellar 
and parasellar tumours.
Four patients in the studied cohort were female (67%). 
Larger case series have also identified a slight female pre-
ponderance, with one recent study identifying 16 (59%) 
females and 11 (41%) males within their 27-patient cohort 
[4]. The mean age of patients in this study was 29, in keep-
ing with the largest case series of xanthogranulomatous 
pituitary lesions to date, which stated a mean age 27 [7]. 
Table 3  Post-operative endocrine function after endoscopic transsphenoidal resection of pituitary xanthogranuloma
– indicates axis deficiency
Pituitary function post op
Corticotrope axis Thyrotrope axis Gonadotrope axis Somatotrope axis ADH axis Prolactin
Case 1 Transient deficiency (normalised 
4 months post-operatively)
– Normal Normal Normal Normal
Case 2 – – – – Normal Normal
Case 3 – Normal – Normal Normal Normal
Case 4 – – – Normal – Normal
Case 5 – – – – Normal Normal
Case 6 Normal Normal Normal Normal Transient DI → 
Normal
Normal
Table 4  Histological features of 
tissue from 6 cases of pituitary 
xanthogranuloma treated by 
endoscopic endonasal resection
+ indicates presence, – indicates absence
Case 1 Case 2 Case 3 Case 4 Case 5 Case 6
Multinucleated giant cells – + – + + +
CD 68 + – + + + –
Haemosiderin – + – – + +
Granuloma – + – + – –
Cholesterol clefts – – – – + +
Granulation tissue – + – – – +
Squamoid epithelium – + + – + +
Histiocytes – – – + + –
Foamy macrophages – – + + + –
T and B lymphocytes – – – + + –
Eosinophils – – – – – –
Necrosis + – – + – –
Plasma cells – – + + – –
Table 5  Comparison of pre- and post-operative visual function in 
cases of pituitary xanthogranuloma
Visual function
Pre-op Post op
Case 1 Normal Normal
Case 2 Normal Normal
Case 3 Incomplete bitemporal hemianopia Normal
Case 4 Incomplete bitemporal hemianopia Normal
Case 5 Incomplete bitemporal hemianopia Normal
Case 6 Left eye—hand movements
Right eye—normal
Normal
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Others have reported mean ages of their pituitary xan-
thogranuloma patients as slightly older (43–46 years) [2, 
9]. This discrepancy likely reflects the low numbers of 
cases in each cohort. However, a trend towards younger 
patients is noted, with only one case reported in a patient 
over the age of 70 [7].
The most common presenting features in our cohort were 
visual deterioration and clinical endocrine dysfunction, at 
least one of which was present in 67% (n = 4) of cases. The 
most common visual deficit was a bitemporal hemianopia 
(n = 3). Three patients (50%) also presented with headaches. 
These clinical manifestations are similar to those reported 
in other series, with endocrine dysfunction, (e.g. diabetes 
insipidus, hypoadrenalism) often reported as the most com-
mon presenting feature [3, 10, 11].
All patients with visual field deficits in our study regained 
normal vision post-operatively. Concordantly, almost all 
patients discussed in the literature are reported to have nor-
mal or near-baseline levels of vision or post-operatively. 
Conversely, endocrinological deficits are rarely reported to 
improve after surgery [4, 9].
Endocrine effects
Four (67%) of our patient cohort presented with biochemi-
cal hyperprolactinaemia. Pre-operative trials of dopamine 
agonists had no effect on tumour size or serum prolactin and 
hyperprolactinaemia resolved in all cases after surgery. In 
total, one patient was free of any hormonal supplementation 
(case 6), and one demonstrated improvement in endocrine 
function, (case 1) at their most recent follow-up (Table 3).
These endocrine outcomes are slightly more promising 
than those previously reported, as in the majority of pub-
lished cases endocrine function rarely improves after xan-
thogranuloma resection and most patients remain on long-
term hormonal supplementation. For instance, Amano et al. 
reported that in their cohort of seven pituitary xanthogranu-
loma patients, 6 cases (86%) presented with pituitary hor-
monal dysfunction, and this persisted in all six patients after 
surgery (3 total resection, 3 sub-total resection) [9].
In a larger analysis of parasellar xanthogranuloma 
patients, the most common presenting symptom was an 
endocrinological deficit (74%; n = 20/27), usually either iso-
lated DI or panhypopituitarism. All 20 cases had persistence 
of their endocrine deficiency post-operatively, with a total 
of 21 patients (77%) requiring hormonal treatment despite 
adequate removal of the pituitary xanthogranuloma [4].
The risk of permanent pituitary dysfunction with sellar 
xanthogranulomas may reflect the time interval between 
symptom onset and surgery, and/or the repetitive inflamma-
tory and haemorrhagic nature of the lesions causing ongo-
ing damage to normal pituitary parenchyma. Therefore, 
the ability to more confidently identify suspected cases of 
xanthogranulomatous pituitary masses is desirable, as this 
could justify expediting surgical intervention, potentially 
permitting more favourable endocrine outcomes [2, 9]. It is 
also possible that meticulous dissection, focus on optic appa-
ratus decompression, and preservation of the pituitary stalk 
when feasible may have contributed to the favourable endo-
crine outcomes achieved in a third of patients in our series. 
In our single case of permanent DI, a decision was taken to 
sacrifice the pituitary stalk in the aim of curative resection 
of a craniopharyngioma; this was probably not necessary 
given the pathology of xanthogranuloma, and could have 
been avoided if the diagnosis was suspected pre-operatively. 
Similarly, the high rate of anterior hypopituitarism following 
surgery compared to surgery for pituitary adenoma, high-
lights the need for clinical suspicion of the diagnosis pre-
operatively to aid patient counselling.
Imaging appearances
No typical radiological signs are thought to highlight xan-
thogranuloma as the most likely possibility in the differen-
tial diagnosis of sellar lesions [6]. This is reflected in the 
fact that xanthogranuloma was not listed in the radiologi-
cal differential diagnosis for any patients in our cohort. The 
most common radiological differential diagnosis was crani-
opharyngioma, which was documented as the most likely 
diagnosis for 3 patients, (50%) prior to their surgeries in the 
present study.
It has been speculated that cholesterol components within 
these lesions should be identifiable from their T1W hyper-
intensity and T2W hypo-intensity on pituitary MR scans, [6, 
12]. However, fluid components within the cystic lesions can 
appear hyperintense on T2W images, and the development 
of more profound fibrosis (granulation) and haemorrhage 
can appear as both T1W and T2W hypointensities [6]. These 
mixed signal intensities reflect the complex histologic com-
ponents that make up granulomatous inflammatory lesions. 
Eighty-three percent (5/6) of cases in our cohort demon-
strated a degree of T1W hyperintensity of their pituitary 
lesions. This is consistent with imaging descriptions in 
other case reports [4, 10, 13], and may represent the cystic 
content and cholesterol clefts before any haemorrhage or 
degeneration of lesion has occurred. However, once a degree 
of necrosis or haemorrhage occurs, the lesions may then 
demonstrate heterogeneous signals on both T1W and T2W 
images, making their differentiation from other cystic lesions 
such as RCC and CPs extremely challenging.
All six patients in this case series demonstrated some 
degree of contrast enhancement of their parasellar lesions; 
three cases (50%) demonstrated peripheral rim enhancement 
of their pituitary lesion on post-contrast T1W scans. Amano 
et al. [9] specified that 71% (5/7) of sellar xanthogranulo-
mas in their series also demonstrated T1W peripheral rim 
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enhancement. The other three cases in our cohort did also 
display contract enhancement, but in a more homogenous 
manner. RCCs do not typically enhance on MRI scans post-
contrast, and calcification is rarely identified. CPs typically 
demonstrate heterogeneous contrast enhancement, and fre-
quently do have calcification identifiable within the cystic 
lesion, particularly in the adamantinomatous sub-type. There 
was no calcification seen in any of the pre-operative MRI 
or CT head scans in our cohort, and thus far only 7 reported 
cases of pituitary xanthogranulomas have demonstrated cal-
cification on imaging [3, 10].
Furthermore, no cases in our cohort demonstrated cav-
ernous sinus involvement, which has been reported for both 
RCCs and CPs [14]. Cavernous sinus involvement remains 
as yet unreported in pituitary xanthogranulomas [4, 9, 10, 
13]. The absence of calcification and cavernous sinus inva-
sion, in the setting of peripheral or global contrast enhance-
ment, may therefore constitute a constellation of imaging 
features that necessitate consideration of xanthogranuloma 
in the pre-operative differential diagnosis.
Table 6 provides a summary of typical features of CPs, 
RCCs and pituitary xanthogranulomas on conventional MR 
imaging. However, these features are not universal to any 
of the lesions, and therefore there are currently no specific 
radiological criteria which can be used differentiate xan-
thogranuloma from other cystic sellar lesions with complete 
confidence.
All lesions analysed in this study had tumour epicentres 
which were universally suprasellar, (Quadrants 1–2) which 
also appears to be a consistent finding in other case series 
[3]. This contrasts to cystic pituitary adenomas and RCCs, 
which typically have an epicentre located in sellar quadrants, 
(quadrants 3 or 4). This supports the notion that pituitary 
xanthogranulomas may hold their origin in the hypothalamo-
infundibular region [2, 9]. A primarily sellar tumour epicen-
tre may therefore suggest cystic adenoma or RCC as more 
likely diagnoses when assessing cystic pituitary lesions.
Non-infectious, xanthogranulomatous inflammation of 
the frontal lobe have been shown to demonstrate restric-
tion of diffusion on diffusion-weighted MR scans [15]. The 
features of CPs and RCCs with diffusion weighted imaging 
(DWI) and MR spectroscopy have been assessed, [11, 12] 
and therefore specific analysis of DWI appearances in 
patients with sellar xanthogranuloma is warranted. If clear 
differences in diffusion restriction between these lesions are 
identified, this modality has the potential to aid clinicians in 
differentiating pituitary xanthogranulomas from other cystic 
sellar lesions prior to surgery.
Histology
Similarities in histological appearances and the consistent 
presence of chronic inflammatory cells and debris in sellar 
xanthogranulomas has fuelled the theory that these lesions 
are on the same spectrum as RCC’s and CPs, potentially 
representing a secondary reaction caused by repeated inflam-
mation and haemorrhage [16]. RCCs consists of simple 
columnar/cuboidal epithelium, whereas CPs are divided into 
histological sub-types: adamantinomatous, (stratified squa-
mous epithelium with keratin nodules +/− calcification) or 
papillary (squamous epithelium).
At least two or more of the characteristic features of 
xanthogranulomas, such as cholesterol clefts, foamy mac-
rophages, granulomas, necrosis, and/or haemosiderin depo-
sition [4, 7, 9] were identified in all patients within the study 
group. In addition, squamous metaplasia was present in 67% 
(4/6) of patients. Le et al. [17] reported that 39%; (11/28) of 
RCCs displayed squamous metaplasia, and that xanthogran-
ulomatous components were identified in 13/28 confirmed 
RCCs (47%). Conversely, xanthogranuloma-like features 
were highlighted in comparatively fewer (n = 5/25; 20%) 
CPs. Amano et al. identified components of RCCs (cuboi-
dal/columnar epithelium, squamous metaplasia) within 86% 
(n = 6/7) of resected pituitary lesions which otherwise com-
posed primarily of xanthogranlomatous material [9]. The 
authors proposed that pituitary xanthogranulomas may rep-
resent a final inflammatory state, resulting from secondary 
reactions caused by repeated haemorrhage, inflammation 
and degeneration of RCCs.
However, identification of residual RCC/CP components 
within pituitary xanthogranulomas is not reported consist-
ently in histological studies across the literature [1, 6, 9, 13]. 
Table 6  Summary of typical 
features of CP, RCC and 
pituitary xanthogranulomas on 
MRI
+ indicates typically present; – indicates typically absent
RCC CP Xanthogranuloma
T1W Hyperintense Heterogeneous Hyper- and/or hypointense
T2W Hypointense Heterogeneous Hyper- or hypointense
Contrast enhancement – Diffuse or peripheral 
enhancement
Peripheral rim or homoge-
neous enhancement
Calcification (on CT scan) – + Rare
Tumour epicentre Usually sellar Usually suprasellar Suprasellar
Cavernous sinus invasion May be present May be present Unreported
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Furthermore, xanthogranuloma histology features are simi-
lar across multiple sites both intracranially and elsewhere 
in the body, and thus they may represent a unique disease 
entity [6, 18].
However, this may be a function of heterogeneity within 
the tissues sent for analysis from pituitary lesions, and thus it 
remains possible that xanthogranulomas represent one con-
dition a spectrum of cystic sellar and parasellar lesions, or 
a stereotyped response to repeated inflammation and haem-
orrhage within a biological structure [18]. Future studies of 
cystic pituitary lesions must ensure that sufficient quantities 
of tissue are sent for histological analysis, to minimise the 
risk of sampling bias when analysing these microscopically 
heterogeneous lesions.
Treatment
Whilst radiotherapy for intracranial xanthogranulomas at 
other sites has been utilised, its use in sellar lesions is yet 
to be evaluated, partly due to the diagnostic uncertainty 
inherent when planning treatment of cystic lesions in this 
region. GTR is considered gold standard treatment for these 
lesions. The endoscopic endonasal approach is generally 
favoured over transcranial approaches when feasible [6]. 
In all patients in our cohort, visual function was normal 
post-operatively, in contrast to endocrine outcomes, which 
improved in 2 patients after long-term follow-up. Recur-
rence or re-growth was not reported in any case during the 
present study’s follow-up period, and recurrence is rarely 
noted in other case reports, regardless whether total or sub-
total resection was performed at the initial operation [1, 4]. 
Given these factors, tumour mass reduction to decompress 
the optic chiasm, with sparing of the pituitary stalk if not 
involved in the lesion, may be regarded as the appropriate 
surgical target when planning resection of a suspected xan-
thogranuloma [9].
However, GTR is advocated for RCCs and CPs. There-
fore, until definitive clinical or radiological diagnostic fea-
tures to identify pituitary xanthogranulomas prior to surgery 
are elucidated, GTR may need to continue to be the surgical 
goal for cystic sellar/parasellar lesions. As the long-term 
prognosis of xanthogranulomatous pituitary lesions after 
surgical removal is yet to be evaluated, close clinical and 
radiologic follow-up is indicated [2, 16, 18].
Conclusion
The prevalence of pituitary xanthogranulomas found in 
our cohort is slightly higher than previously reported in the 
literature. These patients tend to be young at presentation, 
and are likely to present with endocrinological disturbances 
and/or visual deficits. The prognosis for visual function is 
excellent, with most patients having normal or improved 
vision following surgery. The rate of post-operative ante-
rior hypopituitarism is high, but permanent DI is much less 
frequent. Preservation of the pituitary stalk may contribute 
to more favourable endocrine outcomes, particularly given 
the low recurrence rates reported even after subtotal resec-
tions of pituitary xanthogranulomas [9, 10].
Imaging features such as a degree of T1W hyper-intensity 
alongside either peripheral or diffuse contrast enhancement 
have been identified in numerous patients with pituitary 
xanthogranulomas. If these features are identified along-
side a primariy suprasellar tumour epicentre, an absence of 
cavernous sinus invasion, and no identifiable calcification, 
the possibility of sellar/parasellar xanthogranuloma must be 
considered. Appreciation of this rare but important condi-
tion within the differential diagnosis can impact upon patient 
counselling and peri-operative planning from both surgical 
and endocrinological points of view. Characterisation of 
how these lesions appear on advanced imaging modalities, 
such as diffusion weighted imaging, warrants exploration.
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